24 September 2022: Articles
Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease, Adverse events of drug therapy , Educational Purpose (only if useful for a systematic review or synthesis)
Yassine Kilani A* , Haris Sohail B , Chee Yao Lim B , Alyssa Payette E , Syeda Ashna Fatima Kamal E , Afsheen Afzal E , Toqeer Khan E , Nushra Paracha E , Monica Reddy Muppidi A , Daniel Sittler DDOI: 10.12659/AJCR.937500
Am J Case Rep 2022; 23:e937500
Figure 4. Fluorescence in situ hybridization (FISH) study showing a normal nucleus. Screening for MYC break rearrangement (MYCBA) using the XT MYC BA probe showed two orange/green fusion signals, indicating a negative study (see image A, white arrows). The IGH/BCL2 probe was used to detect t(14;18) translocation. Two green signals (IGH) (see image B, blue arrow) and two orange signals (BCL2) (see image B, red arrow) indicate a negative test result for t(14;18) translocation.